glp-1 price drop A Cost That's Hard to (G)u(LP-1) Down π€ PRICE DROP π€ Great
Description
Rising global prevalence of obesity and type 2 diabetes is a primary growth driver for the market
Branco JC, Motta J, Wiener C, et al
For some patients, other approaches may be more appropriate first, or additional evaluation may be needed before starting medication
Abnormal cholesterol levels qualify